New TP53 MASTR

New TP53 MASTR

Molecular Biology

September 29, 2015

Multiplicom is pleased to announce the release of the TP53 MASTR molecular assay, research use only, for the identification of mutations in the entire coding region of TP53.

TP53 is the most frequently mutated gene in cancer and is associated with Li-Fraumeni syndrome, an inherited cancer syndrome. The TP53 MASTR is designed for intended use both on germline material as well as FFPE material.
NGS-based analysis of TP53 mutations has a wide variety of clinical and research applications.

Germline mutation detection

  • for cancer predisposition testing (e.g. Li-Fraumeni syndrome)

Somatic mutation detection

  • for molecular tumor classification and as prognostic biomarker (including leukemia (e.g. CLL, Non-Hodgekin lymphoma), sarcomas, bladder and esophageal cancer)
  • for prediction of therapeutic success (e.g. TP53-targeting drugs and MDM2 inhibitors)
  • for clonality analysis to discriminate primary tumors and metastases

 

The TP53 MASTR has several advantages:

  • clear clinical guidelines to use the test
  • compatible with DNA derived from both FFPE tumor samples and blood

New 917 Ti-Touch Coulometer

New 917 Ti-Touch Coulometer

Molecular Biology

Metrohm is pleased to announce that the successful Ti-Touch titrator family has been expanded by a new member, the 917 Ti-Touch Coulometer.

October 08, 2015 More +
Find better ways to clean up your DNA with Qiagen

Find better ways to clean up your DNA with Qiagen

Molecular Biology

Are you sure you’re using the optimal cleanup kit for all your applications? To ensure excellent results, check out Qiagen’s new online guide to cleanup kits. See which kit fits best for each application, fragment length, sample type and more.

February 23, 2017 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us